Unlimited shares is never good let alone in the OT
Post# of 22940
I do appreciate Bill's comments via Twitter. Assuming at face value this had more to do with the Nevada irregularities vs total authorized, it is easier to accept. However, if that is the case, it would nice to see some strongly worded language/guidance from him on when buyback will commence (or the mysterious triggers IR alludes to), if it has started and how many, and reaffirm revenue guidance for 2017. Unfortunately - shareholders heard/read similar commitments at the end of 2015. Business is always dynamic but in the OTC, one has to be extra diligent in communicating and executing to rise above the majority of shells and scams littering the space. Right rnow, shareholders have seen $109K of revenues booked for 2016 and has yet to be paid. 4Q should be producing revenue but nowhere close to original guidance. Now shareholders are told the company has provided itself a blank check to save $9K a year. While I tend to be miserly both professionally and personally and appreciate the thrift - I am also very aware of expectations when dealing with customers and will spend according to their expectations (dinner, entertainment, etc).
If buyback doesntstart imminently - company could start adding 0.5BB a month to OS at current rate and dropping PPS. Since we dont know how many preferreds are there to be converted - hard to evaluate impact.
At face value - change isnt cataclysmic. In the OTC world - if it doesnt give you major pause - you are in the wrong space. Hoping Bill provides some solid reassuarance on numbers and timeline for those who not only stayed invested through the big runs but also were buying on the way down.